Imago BioSciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Imago BioSciences, Inc. is a biotechnology company focused on discovering medicines for myeloproliferative neoplasms. Based in San Carlos, California, the company operates in the biotechnology research sector and engages in developing targeted therapies, exemplified by IMG-7289, a selective inhibitor of the LSD1 protein. Its work targets advancing treatment options for patients with specific blood-related disorders, addressing unmet medical needs within hematologic oncology. The organization appears to be early in its development stage, with a small internal team, and has pursued leadership appointments and governance activities to support its clinical program and strategic direction. A notable recent development involves the progression of its clinical program and corporate transactions surrounding its strategic partnerships and ownership structure.